CT Cardiomegaly vs Reveal LINQ

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Innolitics
VS
by Medtronic

AI Verdict

Tool A is a software solution designed for automated cardiothoracic ratio measurement from CT images, assisting in the detection of cardiomegaly. In contrast, Tool B is an implantable cardiac monitor that continuously records ECG data, utilizing AI to detect and diagnose cardiac arrhythmias over an extended period. While both leverage AI in cardiology, they address distinct clinical problems and utilize different data modalities and deployment methods.

Choose CT Cardiomegaly if…

Choose CT Cardiomegaly if your clinical workflow requires rapid, automated, and quantitative assessment of cardiothoracic ratio from existing CT chest images. This tool is ideal for radiologists and cardiologists seeking to efficiently screen for or confirm cardiomegaly with objective data, integrating seamlessly into a command-line environment for batch processing or on-demand analysis.

View CT Cardiomegaly →

Choose Reveal LINQ if…

Choose Reveal LINQ if a patient presents with infrequent or unexplained symptoms suggestive of cardiac arrhythmias, necessitating long-term, continuous ECG monitoring for accurate diagnosis. This implantable cardiac monitor is best suited for capturing transient events over an extended period (up to three years), providing AI-powered detection of conditions like atrial fibrillation or cryptogenic stroke that might otherwise go undetected.

View Reveal LINQ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CT Cardiomegaly Reveal LINQ
Pricing Fixed-fee Unknown
Deployment Docker Container (Ubuntu 20.04), command-line software The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs.
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Reveal LINQ

The Reveal LINQ system, with its dedicated bedside patient monitor and clinician mobile app, offers a more intuitive and accessible user experience for both patients and healthcare professionals. In contrast, CT Cardiomegaly is a command-line software, which typically requires a higher level of technical proficiency.

Clinical Value

Reveal LINQ

While both are FDA-cleared and provide valuable clinical data, Reveal LINQ offers continuous, long-term ECG monitoring for up to three years, enabling the detection of elusive and critical cardiac arrhythmias that might otherwise be missed. Its AccuRhythmu2122 AI algorithms specifically aim to reduce false alerts, enhancing diagnostic accuracy and clinician efficiency. CT Cardiomegaly provides quantitative data for cardiomegaly detection from a single CT scan.

Pricing & Value

Tie

Both tools require direct vendor contact for pricing, making a direct comparison of their cost-effectiveness impossible without specific quotes. While Reveal LINQ involves an implantable device and associated procedural costs, its long-term continuous monitoring could offer significant value in preventing serious cardiac events. CT Cardiomegaly, as software, might have a different pricing model (e.g., per-scan or subscription) that could be more accessible for certain use cases.

Enterprise Readiness

Reveal LINQ

Medtronic's Reveal LINQ system, as an implantable medical device supported by a comprehensive ecosystem including a patient monitor, clinician mobile app, and the established CareLink network, demonstrates a higher level of enterprise readiness for widespread clinical adoption and integration into existing healthcare workflows. While Tool A's Docker deployment is enterprise-friendly, Tool B benefits from Medtronic's extensive infrastructure and experience in deploying and supporting complex medical solutions.

Innovation

Reveal LINQ

Reveal LINQ represents a more significant leap in innovation by combining the world's smallest insertable cardiac monitor with long-term continuous monitoring and advanced AI algorithms (AccuRhythmu2122) specifically designed to reduce false alerts and accurately detect complex arrhythmias. This integrated approach to miniaturization, longevity, and intelligent data analysis for critical cardiac conditions is highly innovative. CT Cardiomegaly offers valuable automation of a specific measurement using AI.

Support & Docs

Reveal LINQ

Medtronic, as a global leader in medical technology, offers a more extensive and robust support infrastructure for its Reveal LINQ system, including comprehensive documentation, patient and clinician resources, and dedicated technical support for its CareLink network. While Innolitics provides support for CT Cardiomegaly, the scale and breadth of Medtronic's support ecosystem are likely superior.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CT Cardiomegaly Reveal LINQ
Product Name CT Cardiomegaly Reveal LINQ
Company Innolitics Medtronic
Description FDA-cleared AI-powered command-line software that automatically measures cardiothoracic ratio from CT chest images, assisting physicians in cardiomegaly detection with quantitative data. Tiny, implantable cardiac monitor that continuously records ECG for up to three years, utilizing AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope.
Key Features Automatic cardiothoracic ratio measurement, machine learning algorithms for segmentation, segmentation of heart and thoracic cavity, calculates linear and area-based cardiothoracic ratios, outputs PDF and JSON reports. World's smallest insertable cardiac monitor (1.2 mL), continuous ECG monitoring for up to three years, AccuRhythmu2122 AI algorithms for reduced false alerts (AF and pause), automatic and patient-activated event recording, MRI Conditional (1.5T and 3T).
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Radiology Cardiology, Neurology

Videos

Demos, reviews, and walkthroughs featuring CT Cardiomegaly and Reveal LINQ.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

CT Cardiomegaly is designed to assist physicians in detecting cardiomegaly by automatically measuring the cardiothoracic ratio from CT chest images. Reveal LINQ is an implantable cardiac monitor that continuously records ECG for up to three years, utilizing AI algorithms to detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope.
CT Cardiomegaly provides quantitative linear and area-based cardiothoracic ratio measurements, outputting results in PDF and JSON reports. Reveal LINQ offers continuous ECG recordings for up to three years, along with automatic and patient-activated event recordings for arrhythmia detection.
CT Cardiomegaly uses machine learning algorithms for the segmentation of the heart and thoracic cavity to automatically calculate cardiothoracic ratios. Reveal LINQ incorporates AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias and to significantly reduce false alerts for atrial fibrillation and pause.
CT Cardiomegaly is designed for use in Cardiology and Radiology specialties. Reveal LINQ is primarily utilized in Cardiology and Neurology for its capabilities in cardiac arrhythmia detection and diagnosis.
CT Cardiomegaly's machine learning algorithms for segmentation and cardiothoracic ratio calculation have been validated against manual measurements performed by board-certified radiologists. Reveal LINQ utilizes AccuRhythmu2122 AI algorithms, which were developed using Medtronic's database of over a million ECG heart rhythm episodes and are designed for accurate detection and diagnosis of cardiac arrhythmias and for reducing false alerts.
AI Tool Finder
AI-powered search. Results may not be comprehensive.